AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16950462 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard M-mode AVPD
Number of subjects: 56
Study 16950462 — intervention group
Group type: EXPERIMENTAL
Intervention: Color TD M-mode AVPD
Number of subjects: 56
Study 16950462 — intervention group
Group type: COMPARATOR
Intervention: Pulsed TD
Number of subjects: 56
Study 15608809 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Prescription physical activity counselling programme (verbal advice and written exercise prescription with telephone follow-up)
Number of subjects: 878
Study 15608809 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 878
Study 15608809 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Prescription physical activity counselling programme
Number of subjects: 878
Study 10517718 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconventional therapies
Number of subjects: 16068
Study 10517718 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical care
Number of subjects: 16068
Study 10517718 — intervention group
Group type: EXPERIMENTAL
Intervention: Both unconventional therapies and conventional medical care
Number of subjects: 16068
Study 7717834 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team evaluation
Number of subjects: 40
Study 7717834 — intervention group
Group type: COMPARATOR
Intervention: Physiatrist evaluation
Number of subjects: 40
Study 2387803 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder telephone call
Number of subjects: 0
Study 2387803 — intervention group
Group type: EXPERIMENTAL
Intervention: Orientation letter
Number of subjects: 0
Study 2387803 — intervention group
Group type: EXPERIMENTAL
Intervention: Both a telephone prompt and an orientation letter
Number of subjects: 0
Study 2387803 — intervention group
Group type: COMPARATOR
Intervention: No contact
Number of subjects: 0
Study 6169671 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of human leukocyte interferon (HLI) ointment (4,000 units/g) for 4 weeks
Number of subjects: 18
Study 6169671 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of human leukocyte interferon (HLI) in the form of powder and solution
Number of subjects: 18
Study 6169671 — intervention group
Group type: COMPARATOR
Intervention: Combined local and general therapy
Number of subjects: 18
Study 31725504 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative position of contour height of zygomatic bone (male)
Number of subjects: 108
Study 31725504 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative prominence of zygomatic bone (male)
Number of subjects: 108
Study 31725504 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative prominence of zygomatic arch (male)
Number of subjects: 108
Study 31841496 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 17
Study 31841496 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA followed by intralesional 5-fluorouracil (5-FU) injections
Number of subjects: 17
Study 31841496 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA
Number of subjects: 17
Study 31841496 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of RFA with verapamil and 5-FU
Number of subjects: 17
Study 31841496 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA as monotherapy or in combination with chemotherapy
Number of subjects: 17
Study 29441450 — intervention group
Group type: EXPERIMENTAL
Intervention: Active photobiomodulation plus physiotherapy
Number of subjects: 25
Study 29441450 — intervention group
Group type: COMPARATOR
Intervention: Placebo photobiomodulation plus physiotherapy
Number of subjects: 25
Study 27616885 — intervention group
Group type: EXPERIMENTAL
Intervention: Theracurmin(®) 90 mg twice a day for 24 weeks
Number of subjects: 39
Study 27616885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 24602923 — intervention group
Group type: EXPERIMENTAL
Intervention: Simeprevir (150 mg, once daily) and peg-interferon α-2a and ribavirin (PR)
Number of subjects: 393
Study 24602923 — intervention group
Group type: COMPARATOR
Intervention: Placebo and peg-interferon α-2a and ribavirin (PR)
Number of subjects: 393
Study 22341737 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 1391
Study 22341737 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1391
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD treatment
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: New York Heart Association class > II
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: QRS >120 ms
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate ≥ 80
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic therapy
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Prerenal azotemia (BUN:creatinine > 20)
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Occurrence of 1 HF event
Number of subjects: 1218
Study 20455991 — intervention group
Group type: EXPERIMENTAL
Intervention: Occurrence of 2 HF events
Number of subjects: 1218
Study 17061151 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative multidisciplinary intervention program
Number of subjects: 199
Study 17061151 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 199
Study 17061151 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative multidisciplinary intervention program (specifically for patients with dementia)
Number of subjects: 199
Study 17061151 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care for patients with dementia)
Number of subjects: 199
Study 16267706 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radio-chemotherapy
Number of subjects: 32
Study 16267706 — intervention group
Group type: COMPARATOR
Intervention: No postoperative therapy
Number of subjects: 32
Study 11867410 — intervention group
Group type: EXPERIMENTAL
Intervention: IV tropisetron 5 mg
Number of subjects: 120
Study 11867410 — intervention group
Group type: COMPARATOR
Intervention: IV dexamethasone 5 mg
Number of subjects: 120
Study 11867410 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 120
Study 10395859 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% gel (Conceptrol)
Number of subjects: 48
Study 10395859 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5% gel (Advantage-24)
Number of subjects: 48
Study 10395859 — intervention group
Group type: EXPERIMENTAL
Intervention: 28% vaginal contraceptive film
Number of subjects: 48
Study 10395859 — intervention group
Group type: EXPERIMENTAL
Intervention: All N-9 preparations
Number of subjects: 48
Study 10395859 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 48
Study 7759462 — intervention group
Group type: EXPERIMENTAL
Intervention: Midaglizole (MID) 200 mg pre- and post-treatment
Number of subjects: 4
Study 7759462 — intervention group
Group type: EXPERIMENTAL
Intervention: Midaglizole (MID) 200 mg pretreatment
Number of subjects: 4
Study 7759462 — intervention group
Group type: EXPERIMENTAL
Intervention: Midaglizole (MID) 200 mg posttreatment
Number of subjects: 4
Study 7759462 — intervention group
Group type: COMPARATOR
Intervention: Allergen alone (control phase)
Number of subjects: 4
Study 31975265 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary clinical pathway protocol implemented after 2012
Number of subjects: 247
Study 31975265 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics dosed within 1 hour
Number of subjects: 247
Study 31975265 — intervention group
Group type: EXPERIMENTAL
Intervention: Redosing of antibiotics
Number of subjects: 247
Study 31975265 — intervention group
Group type: EXPERIMENTAL
Intervention: Betadine irrigation
Number of subjects: 247
Study 31975265 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin administration
Number of subjects: 247
Study 31975265 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliant antibiotics dosing
Number of subjects: 247
Study 28647549 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 728
Study 28647549 — intervention group
Group type: COMPARATOR
Intervention: Standard procedures (Control)
Number of subjects: 728
Study 25788030 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow gastric tube (NGT) reconstruction
Number of subjects: 104
Study 25788030 — intervention group
Group type: COMPARATOR
Intervention: Whole-stomach (WS) reconstruction
Number of subjects: 104
Study 23281646 — intervention group
Group type: COMPARATOR
Intervention: Implementation of quality indicators based on evidence-based guidelines for CS in 12 hospitals (6 intervention hospitals).
Number of subjects: 2000
Study 23281646 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality indicators measuring adherence to guideline recommendations on CS.
Number of subjects: 2000
Study 23281646 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviews with healthcare professionals and patients.
Number of subjects: 2000
Study 21166610 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 548
Study 21166610 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-Care (SOC) - olanzapine, quetiapine, risperidone
Number of subjects: 548
Study 18325135 — intervention group
Group type: EXPERIMENTAL
Intervention: diet C (increased consumption of cereals, especially breakfast cereals)
Number of subjects: 57
Study 18325135 — intervention group
Group type: EXPERIMENTAL
Intervention: diet C
Number of subjects: 57
Study 18325135 — intervention group
Group type: COMPARATOR
Intervention: diet V (increased consumption of vegetables)
Number of subjects: 57
Study 18325135 — intervention group
Group type: COMPARATOR
Intervention: diet V
Number of subjects: 57
Study 17717913 — intervention group
Group type: EXPERIMENTAL
Intervention: Total panax notoginseng saponins (PNS)
Number of subjects: 84
Study 17717913 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy with diclofenac sodium, Leflunomide and prednisone
Number of subjects: 84
Study 14996523 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide via dry-powder inhaler
Number of subjects: 945
Study 14996523 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide via pressurized metered-dose inhaler
Number of subjects: 945
Study 14996523 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 945
Study 14996523 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide
Number of subjects: 945
Study 11318886 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometheptene mucate, dichloralphenazone with acetaminophen
Number of subjects: 137
Study 11318886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan succinate
Number of subjects: 137
Study 9389263 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter lower alarm limit set at 90% (group 90)
Number of subjects: 647
Study 9389263 — intervention group
Group type: COMPARATOR
Intervention: Pulse oximeter lower alarm limit set at 85% (group 85)
Number of subjects: 647
Study 9389263 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter lower alarm limit set at 90% with a theoretical delay of 15 s
Number of subjects: 647
Study 7943128 — intervention group
Group type: EXPERIMENTAL
Intervention: Patching of the eyes from birth to a gestational age of 35 weeks
Number of subjects: 127
Study 7943128 — intervention group
Group type: COMPARATOR
Intervention: Cycled lighting conditions (reduced light level during the night)
Number of subjects: 127
Study 3794875 — intervention group
Group type: EXPERIMENTAL
Intervention: GH plus Cyproheptadine (Cp) 0.25 to 0.4 mg/kg/day
Number of subjects: 6
Study 3794875 — intervention group
Group type: COMPARATOR
Intervention: GH alone
Number of subjects: 6
Study 3794875 — intervention group
Group type: EXPERIMENTAL
Intervention: GH plus Cyproheptadine (Cp)
Number of subjects: 6
Study 30447891 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate 524 mg administered 30 min before DMF
Number of subjects: 175
Study 30447891 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 30 min before DMF
Number of subjects: 175
Study 27753427 — intervention group
Group type: EXPERIMENTAL
Intervention: Video chat monitoring for dietary adherence
Number of subjects: 0
Study 27753427 — intervention group
Group type: EXPERIMENTAL
Intervention: Video chat monitoring for pill-taking adherence
Number of subjects: 0
Study 27753427 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey results from study 2
Number of subjects: 0
Study 26516614 — intervention group
Group type: EXPERIMENTAL
Intervention: l-dopa (Levodopa) administered preoperatively
Number of subjects: 11
Study 26516614 — intervention group
Group type: EXPERIMENTAL
Intervention: cZi-DBS (deep brain stimulation in caudal zona incerta)
Number of subjects: 11
Study 23442368 — intervention group
Group type: EXPERIMENTAL
Intervention: $500 electricity voucher paid into the electricity account of older people with COPD (early intervention group)
Number of subjects: 522
Study 23442368 — intervention group
Group type: EXPERIMENTAL
Intervention: $500 electricity voucher paid into the electricity account of older people with COPD (late intervention group)
Number of subjects: 522
Study 23442368 — intervention group
Group type: COMPARATOR
Intervention: Control group (late intervention)
Number of subjects: 522
Study 20178677 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive-behavior therapy (TF-CBT) or eye movement desensitization and reprocessing (EMDR)
Number of subjects: 910
Study 20178677 — intervention group
Group type: COMPARATOR
Intervention: Outreach and screening
Number of subjects: 910
Study 18808489 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense intervention (n = 54)
Number of subjects: 176
Study 18808489 — intervention group
Group type: EXPERIMENTAL
Intervention: Less-intense intervention (n = 58)
Number of subjects: 176
Study 18808489 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 64)
Number of subjects: 176
Study 18808489 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense intervention
Number of subjects: 176
Study 18808489 — intervention group
Group type: EXPERIMENTAL
Intervention: Less-intense intervention
Number of subjects: 176
Study 18808489 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 176
Study 16015461 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreeable behaviour (communal behaviour manipulation)
Number of subjects: 66
Study 16015461 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarrelsome behaviour (communal behaviour manipulation)
Number of subjects: 66
Study 16015461 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarrelsome behaviour (low communal trait)
Number of subjects: 66
Study 16015461 — intervention group
Group type: EXPERIMENTAL
Intervention: Low communal men
Number of subjects: 66
Study 16015461 — intervention group
Group type: EXPERIMENTAL
Intervention: High communal women
Number of subjects: 66
Study 12548209 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin 5 mg/kg and clindamycin phosphate 2700 mg administered as a single‐daily dose
Number of subjects: 110
Study 12548209 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin 1.5 mg/kg and clindamycin phosphate 900 mg administered every 8 hours
Number of subjects: 110
Study 10368355 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE)
Number of subjects: 29
Study 10368355 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 29
Study 8902446 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (5 mg) administered orally, daily for 3-6 months
Number of subjects: 40
Study 8902446 — intervention group
Group type: COMPARATOR
Intervention: Control group (37 men with significant antisperm antibodies)
Number of subjects: 40
Study 2050169 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine + alcohol
Number of subjects: 7
Study 2050169 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline + alcohol
Number of subjects: 7
Study 2050169 — intervention group
Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 7
Study 2050169 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 7
Study 2050169 — intervention group
Group type: EXPERIMENTAL
Intervention: Both antidepressants (amitriptyline and imipramine)
Number of subjects: 7
Study 2050169 — intervention group
Group type: EXPERIMENTAL
Intervention: Digit symbol substitution test
Number of subjects: 7
Study 6364591 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) ointment (200 mg applied three times a day for 3 weeks)
Number of subjects: 12
Study 6364591 — intervention group
Group type: COMPARATOR
Intervention: Placebo (applied three times a day for 3 weeks)
Number of subjects: 12
Study 31345267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of durvalumab (1500 mg IV every 4 weeks), olaparib (300 mg twice daily), and cediranib (20 mg, 5 days on/2 days off)
Number of subjects: 9
Study 31345267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of durvalumab, olaparib, and cediranib
Number of subjects: 9
Study 29473942 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphical instructions
Number of subjects: 92
Study 29473942 — intervention group
Group type: COMPARATOR
Intervention: Standardized instructions
Number of subjects: 92
Study 26402148 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 220
Study 26402148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 23979220 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinegar in palatable drinks
Number of subjects: 30
Study 23979220 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinegar in unpalatable drinks
Number of subjects: 30
Study 23979220 — intervention group
Group type: COMPARATOR
Intervention: Orosensory stimulation with vinegar (taste only without ingestion)
Number of subjects: 30
Study 23979220 — intervention group
Group type: COMPARATOR
Intervention: Non-vinegar control
Number of subjects: 30
Study 22201663 — intervention group
Group type: EXPERIMENTAL
Intervention: P6 acupressure plus nurse-provided counseling
Number of subjects: 120
Study 22201663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-provided counseling
Number of subjects: 120
Study 22201663 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo on SI3)
Number of subjects: 120
Study 22201663 — intervention group
Group type: EXPERIMENTAL
Intervention: P6 acupressure only
Number of subjects: 120
Study 20117624 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release
Number of subjects: 72
Study 20117624 — intervention group
Group type: COMPARATOR
Intervention: Open carpal tunnel release
Number of subjects: 72
Study 17038536 — intervention group
Group type: EXPERIMENTAL
Intervention: Unrelated cord blood transplantation (CBT)
Number of subjects: 171
Study 17038536 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow transplant (BMT) or peripheral blood stem-cell transplant (PBSCT)
Number of subjects: 171
Study 14994322 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (mean daily dose 439.5 mg, range 150-750 mg)
Number of subjects: 258
Study 14994322 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (mean daily dose 438.5 mg, range 150-750 mg)
Number of subjects: 258
Study 11339781 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml of 2% mepivacaine via an epidural catheter inserted cephaladly (Group A)
Number of subjects: 46
Study 11339781 — intervention group
Group type: COMPARATOR
Intervention: 5 ml of 2% mepivacaine directly in the epidural needle directed caudally and 10 ml of 2% mepivacaine via the epidural catheter inserted cephaladly (Group B)
Number of subjects: 46
Study 11339781 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 46
Study 9731851 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1200 mg elemental calcium per day)
Number of subjects: 497
Study 9731851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 497
Study 7520105 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (FK506)
Number of subjects: 545
Study 7520105 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin
Number of subjects: 545
Study 2662803 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural diamorphine 5 mg with bupivacaine 0.25% 10 ml
Number of subjects: 50
Study 2662803 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.25% 10 ml
Number of subjects: 50
Study 1200020 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training exercise program
Number of subjects: 0
Study 1200020 — intervention group
Group type: COMPARATOR
Intervention: Low intensity activities (control group)
Number of subjects: 0
Study 31506246 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-walking (WW)
Number of subjects: 72
Study 31506246 — intervention group
Group type: EXPERIMENTAL
Intervention: Land-walking (LW)
Number of subjects: 72
Study 31506246 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 72
Study 30195244 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-enriched fish oil supplement
Number of subjects: 0
Study 30195244 — intervention group
Group type: COMPARATOR
Intervention: Grilled fish (100 g per day)
Number of subjects: 0
Study 30195244 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (fish oil and fish meal)
Number of subjects: 0
Study 28712537 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral, subretinal injection of 1·5×10^11 vector genomes of voretigene neparvovec in 0·3 mL total volume
Number of subjects: 31
Study 28712537 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 31
Study 28712537 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral, subretinal injection of voretigene neparvovec
Number of subjects: 31
Study 26720026 — intervention group
Group type: EXPERIMENTAL
Intervention: Opiates (n=150)
Number of subjects: 320
Study 26720026 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (n=144)
Number of subjects: 320